Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on X about a recent article by Michele Carbone at al, published in Journal of Thoracic Oncology:
Title: Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations
Authors: Michele Carbone, Michael Minaai, Muaiad Kittaneh, Thomas Krausz, Markku M. Miettinen, Qiang Pan Hammarström, Lennart Hammarström, Hassan Abolhassani, Ian Pagano, Ronghui Xu, Flavia Novelli, Giovanni Gaudino, Sandra Pastorino, Kavita Y. Sarin, Robert T. Ripley, Harvey I. Pass, David S. Schrump, Haining Yang
Read the Full Article on Journal of Thoracic Oncology
More posts about Mesotheliomas.